This article is more than 5 years old. Information may no longer be current.
Cloud-based diabetic retinopathy screening tool granted CE approval
Click Here to Manage Email Alerts
IDx announced that a cloud-based version of its diabetic retinopathy screening product has received CE approval as a Class 2a medical device, according to a company press release.
The IDx-DR version 1.3 device provides HIPAA-compliant, cloud-based screening for diabetic retinopathy to health care providers across the internet.
Eliminating the need for a series of complex computations at the provider’s location, the cloud-based software utilizes a series of high-end processors to analyze retinal images and produce results to the provider within seconds, while advanced encryption protects patient data throughout the entire process, according to the release.
As a result of the approval, the automated diabetic retinopathy screening device will now be available to providers across 31 countries in the European economic area.